GuideGLP-1 Hub
Beyond the Scale: The SELECT Trial and Heart Health
What a large trial found about heart attacks, strokes and cardiovascular deaths in people with excess weight and existing heart disease, and what it cannot tell us.
Latest articles
GLP-1 Hub
News, research and clear explainers on GLP-1 medications.
GuideGLP-1 Hub
Side Effects in the Big GLP-1 Trials: The Numbers Behind Nausea, Diarrhea and More
What the two landmark weight-management trials found about nausea, diarrhea and other side effects, and what the FDA label warns about. Education only, not medical advice.
GuideGLP-1 Hub
Approved vs. Compounded: How GLP-1 Medications Are Regulated
A clear look at how the FDA approves GLP-1 medications, what compounding is, and why the agency treats the two differently. Education only, with no product advice.
GuideGLP-1 Hub
Muscle Loss on GLP-1 Medications: The Known and the Unknown
Some lean mass is lost with almost any weight loss. Here is what the two main body-composition studies found for GLP-1 medications, and what is still unknown.
GuideGLP-1 Hub
Stopping a GLP-1 Medication: Weight, Appetite and Next Steps
Two large trials followed people after they stopped GLP-1 medications. Here is what they found about weight regain and health markers, and what to ask your prescriber.
NewsGLP-1 Hub
How GLP-1 Medications Are Changing the Way People Shop for Food
A Cornell study using real purchase records from about 150,000 households found grocery spending fell about 5% after a household started a GLP-1 medication, mostly on snacks, sweets and fast food.